Brief: Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation At Escmid Global 2025
08/04/2025 12:05
April 8 (Reuters) - Enanta Pharmaceuticals Inc ENTA.O: ENANTA PHARMACEUTICALS ANNOUNCES RESPIRATORY SYNCYTIAL VIRUS DATA PRESENTATION AT ESCMID GLOBAL 2025 Source text: ID:nBw6dk25ya Further company coverage: ENTA.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Enanta Pharmaceuticals
See all newsEnanta Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Enanta Pharmaceuticals Q3 revenue misses estimates, hurt by lower royalties
Enanta Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs
Enanta Pharmaceuticals Q1 revenue beats estimates